These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1309261)

  • 1. Polyomavirus large and small T antigens cooperate in induction of the S phase in serum-starved 3T3 mouse fibroblasts.
    Ogris E; Mudrak I; Wintersberger E
    J Virol; 1992 Jan; 66(1):53-61. PubMed ID: 1309261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct amounts of polyomavirus large T antigen are required for different functions of the protein.
    Ogris E; Mudrak I; Wintersberger E
    Oncogene; 1993 May; 8(5):1277-83. PubMed ID: 8386826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated trans activation of DNA synthesis- and precursor-producing enzymes by polyomavirus large T antigen through interaction with the retinoblastoma protein.
    Mudrak I; Ogris E; Rotheneder H; Wintersberger E
    Mol Cell Biol; 1994 Mar; 14(3):1886-92. PubMed ID: 7906859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of early-response genes during polyomavirus infection.
    Glenn GM; Eckhart W
    J Virol; 1990 May; 64(5):2193-201. PubMed ID: 1691311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyomavirus hr-t mutant-specific induction of a G2/M cell-cycle arrest that is not overcome by the expression of middle T and/or small T.
    Spink KM; Fluck MM
    Virology; 2003 Mar; 307(2):191-203. PubMed ID: 12667790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lytic functions of mutant polyomavirus large T-antigen with deletion of retinoblastoma protein-binding motif.
    Söderbärg K; Magnusson G
    Virology; 1993 Mar; 193(1):281-8. PubMed ID: 8382398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transactivation of murine cyclin A by polyomavirus large and small T antigens.
    Schüchner S; Nemethova M; Belisova A; Klucky B; Holnthoner W; Wintersberger E
    J Virol; 2001 Jul; 75(14):6498-507. PubMed ID: 11413317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small and middle T antigens contribute to lytic and abortive polyomavirus infection.
    Türler H; Salomon C
    J Virol; 1985 Feb; 53(2):579-86. PubMed ID: 2578576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of middle T-small T in the lytic cycle of polyomavirus: control of the early-to-late transcriptional switch and viral DNA replication.
    Chen L; Fluck MM
    J Virol; 2001 Sep; 75(18):8380-9. PubMed ID: 11507183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of the steps of the polyomavirus lytic cycle.
    Chen L; Fluck M
    J Virol; 2001 Sep; 75(18):8368-79. PubMed ID: 11507182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyomavirus large T antigen overcomes p53 dependent growth arrest.
    Doherty J; Freund R
    Oncogene; 1997 Apr; 14(16):1923-31. PubMed ID: 9150359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonlethal mutation in large T antigen of polyomavirus which affects viral DNA synthesis.
    Hacker DL; Friderici K; Fluck MM
    J Virol; 1989 Feb; 63(2):776-81. PubMed ID: 2536103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of JE and KC genes by glucocorticoids does not prevent the G0----G1 transition in BALB/3T3 cells.
    Rameh LE; Armelin MC
    Mol Cell Biol; 1992 Oct; 12(10):4612-21. PubMed ID: 1406651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on polyomavirus T-antigen function of mutations in a conserved leucine-rich segment of the DnaJ domain.
    Li H; Söderbärg K; Houshmand H; You ZY; Magnusson G
    J Virol; 2001 Mar; 75(5):2253-61. PubMed ID: 11160729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A viable mouse polyomavirus mutant without immortalizing or transforming activities.
    Linder S; Nilsson M; Martens I; Magnusson G
    Virology; 1990 Nov; 179(1):78-86. PubMed ID: 2171224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host range and cell cycle activation properties of polyomavirus large T-antigen mutants defective in pRB binding.
    Freund R; Bauer PH; Crissman HA; Bradbury EM; Benjamin TL
    J Virol; 1994 Nov; 68(11):7227-34. PubMed ID: 7933105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids facilitate the stable transformation of embryonal rat fibroblasts by a polyomavirus large tumor antigen-deficient mutant.
    Martens I; Nilsson M; Magnusson G; Linder S
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5571-5. PubMed ID: 2840668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancer-mediated role for polyomavirus middle T/small T in DNA replication.
    Chen MC; Redenius D; Osati-Ashtiani F; Fluck MM
    J Virol; 1995 Jan; 69(1):326-33. PubMed ID: 7983726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyomavirus transforms rat F111 and mouse NIH 3T3 cells by different mechanisms.
    Raptis L; Bolen JB
    J Virol; 1989 Feb; 63(2):753-8. PubMed ID: 2463382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T antigens' role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle T.
    Rameh LE; Armelin MC
    Oncogene; 1991 Jun; 6(6):1049-56. PubMed ID: 1648700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.